文献速递外周动脉疾病

编者按:股总动脉粥样硬化病变适合血管内治疗的比例——CONFESS研究

Editor's Choice - Eligibility of Common Femoral Artery Atherosclerotic Disease for Endovascular Treatment - the CONFESS Study.
PubMed 文献 · Eur J Vasc Endovasc Surg · 2022-09-06

该观察性研究纳入2014年1月至2018年12月两家三级NHS医院因症状性外周动脉疾病行股总动脉内膜剥脱术的737例连续患者(829条股总动脉),通过术前CT血管造影三维重建分析斑块形态与成分。结果显示45%的靶血管无严重钙化负荷且股总动脉、股深动脉及股浅动脉近端通畅,可能适合血管内治疗;33%的股总动脉存在显著钙化负荷,可能需要支架置入。作者认为相当比例接受手术的股总动脉粥样硬化病变患者可能为血管内治疗候选者,需开展随机试验比较股总动脉内膜剥脱术与新型血管内技术。

要点

  • 45%的靶血管无严重钙化负荷且股总动脉、股深动脉及股浅动脉近端通畅,可能适合血管内治疗。
  • 33%的股总动脉存在显著钙化负荷,可能需要支架置入。
  • 35%的股总动脉为局限性病变(无分叉病变),可能适合血管内治疗。

核心结论

  • 相当比例接受手术的股总动脉粥样硬化病变患者可能为血管内治疗候选者,需开展随机试验比较股总动脉内膜剥脱术与新型血管内技术。

研究设计与样本

  • 观察性研究,纳入2014年1月至2018年12月两家三级NHS医院因症状性外周动脉疾病行股总动脉内膜剥脱术的737例连续患者(829条股总动脉),平均年龄71±10岁,男性526例(71%),451条(62%)表现为慢性肢体威胁性缺血。

主要发现

  • 35%的股总动脉为局限性病变(无分叉病变),可能适合血管内治疗。
  • 376条(45%)靶血管无严重钙化负荷,且股总动脉、股深动脉及股浅动脉近端通畅,可能适合血管内治疗。
  • 271条股总动脉(33%)存在显著钙化负荷,可能需要支架置入。

关键数值与推荐

  • 股总动脉病变适合血管内治疗的标准为:髂动脉流入道通畅、至少一条流出道血管(股浅动脉或股深动脉)通畅、股总动脉狭窄而非闭塞。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: Advances in endovascular technologies have allowed the treatment of common femoral artery (CFA) steno-occlusive disease by minimally invasive means; however, the proportion of lesions treated with common femoral artery endarterectomy (CFAE) which would be amenable to endovascular treatment is unknown. This observational study aimed to describe the morphology and composition of CFA lesions treated with CFAE and report the proportion that would be amenable to endovascular treatment with modern technologies. METHODS: Patients presenting with symptomatic peripheral artery disease who underwent CFAE from January 2014 to December 2018 in two tertiary NHS hospitals were included. Extensive data relating to patient demographics, risk factors, clinical outcomes, as well as anatomical and morphological characteristics of the CFA atherosclerotic lesions, were collected which included detailed plaque analysis using 3D reconstruction of pre-operative computed tomography angiograms. CFA lesions were considered suitable for endovascular treatment if presented with patent iliac inflow, at least one patent outflow vessel (superficial femoral artery [SFA] or profunda femoral artery [PFA]), and stenotic rather than occluded CFA. RESULTS: A total of 829 CFAs in 737 consecutive patients who underwent CFAE were included (mean age 71 ± 10 years; 526 males, 71%); 451 (62%) presented with chronic limb threatening ischaemia. Overall, 35% of CFAs had a localised lesion (no bifurcation disease) that could possibly be treated endovascularly. In total, 376 (45%) target vessels did not feature severe calcium load, with a patent CFA, PFA, and proximal SFA and therefore would have been amenable to endovascular treatment; while 271 CFAs (33%) featured a significant calcium load which would have potentially required stenting. CONCLUSION: A significant proportion of patients with atherosclerotic CFA lesions who undergo surgery could potentially be candidates for endovascular treatment. A randomised trial comparing CFAE and new endovascular techniques in this clinical context is required.

来源:Eur J Vasc Endovasc Surg,查看原文。版权归原作者所有。

引用

  1. Kaneta G, Husain S, Musto L, et al. Editor's Choice - Eligibility of Common Femoral Artery Atherosclerotic Disease for Endovascular Treatment - the CONFESS Study. Eur J Vasc Endovasc Surg. 2022. PMID: 36075540. doi:10.1016/j.ejvs.2022.08.034

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。